D-0473-2018 Class III Terminated
FDA drug recall D-0473-2018 was initiated by Nostrum Laboratories Inc on Feb 13, 2018 and is designated Class III. Reason for recall: Presence of Foreign Tablets/Capsules The recall status is terminated (terminated Dec 13, 2018). Affected quantity: 1,439,000 oral capsules.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 28, 2018
- Initiation Date
- Feb 13, 2018
- Termination Date
- Dec 13, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,439,000 oral capsules
Product description
Calcium Acetate Capsules, 667 mg, 200 Capsules per bottle, Rx Only. Manufactured by Nostrum Laboratories, Inc. Kansas City, MO 64120. NDC 29033-026-02
Reason for recall
Presence of Foreign Tablets/Capsules
Distribution pattern
Nationwide
Code information
Lot: CAL173502; Exp. 09/19
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0473-2018
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026